Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.672, 2013-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bevacizumab "best value for money" in MCRC . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 666, 2012-01 ,pp. :
PUVA, ciclosporin, or methotrexate best value for severe psoriasis
Inpharma, Vol. 1, Iss. 1532, 2006-01 ,pp. :
Atorvastatin best value for money for secondary CHD prevention
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 408-409, 2003-01 ,pp. :
Topical Corticosteroids in Nasal Polyposis
Drugs, Vol. 61, Iss. 5, 2001-01 ,pp. :
Which antifungal agents best value for money in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 433, 2003-01 ,pp. :